![Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center](https://www.frontiersin.org/files/Articles/747704/fendo-12-747704-HTML/image_m/fendo-12-747704-g001.jpg)
Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various hi
![Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature](https://www.mdpi.com/cancers/cancers-02-00885/article_deploy/html/images/cancers-02-00885-g001.png)
Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature
![Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/749973/749973_Thumb_400.jpg)
Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
![Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1575092215000327:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNf23BlP/DWEpPOpuWlfofnyU0Zzc7C+spQedaWXFRWdfa8E9RzH5OP6vqtd1YS/HjxOdTYJx4RbzWm1a7GceCWP3qYF4inzpywlsiBYzFsxK/QwT1Nm5JzzqbYwZvjC2q1Y6/y4423nzIlPJCY9uaPs2ZTbhP6Sb7en8QVZki5EDYklbWH3IwZb0lEkN4XZZudXAV2NXGAe+8oh+DoRQXjNMtX/hXtUlA3F/wvqP/Z25w+eWjEPrmJK3L+9gL4+cu0=)
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for
![SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma](https://minio.scielo.br/documentstore/1980-5322/3R5NJTvSjD9SCNcY5CdkWpN/d667d43f01beb7557cdafbb931cc600bc2193e4f.gif)
SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma
![High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/4224a0ec-8757-4440-8cbf-58166db98b46/gr1.jpg)
High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice
![Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review](https://www.frontiersin.org/files/Articles/526716/fonc-10-526716-HTML/image_m/fonc-10-526716-g001.jpg)
Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
![Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1974/nejm_1974.290.issue-19/nejm197405092901901/20130816/images/img_medium/nejm197405092901901_f5.jpeg)